L

Lepu Medical Technology Beijing Co Ltd
SZSE:300003

Watchlist Manager
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Watchlist
Price: 11.91 CNY 0.25% Market Closed
Market Cap: 22.4B CNY
Have any thoughts about
Lepu Medical Technology Beijing Co Ltd?
Write Note

Net Margin
Lepu Medical Technology Beijing Co Ltd

10.9%
Current
17%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
707.3m
/
Revenue
6.5B

Net Margin Across Competitors

Country CN
Market Cap 22.4B CNY
Net Margin
11%
Country US
Market Cap 199B USD
Net Margin
14%
Country US
Market Cap 191.3B USD
Net Margin
29%
Country US
Market Cap 141.3B USD
Net Margin
16%
Country US
Market Cap 134.2B USD
Net Margin
11%
Country IE
Market Cap 104.6B USD
Net Margin
13%
Country US
Market Cap 65.6B USD
Net Margin
9%
Country DE
Market Cap 58.1B EUR
Net Margin
8%
Country US
Market Cap 44.5B USD
Net Margin
74%
Country CN
Market Cap 311.1B CNY
Net Margin
33%
Country US
Market Cap 36.3B USD
Net Margin
9%
No Stocks Found

Lepu Medical Technology Beijing Co Ltd
Glance View

Market Cap
22.4B CNY
Industry
Health Care

Lepu Medical Technology Beijing Co Ltd. was born in the vibrant landscape of China's rapidly evolving healthcare industry. Established in 1999, the company has grown into a formidable player in the medical device sector. It carved its niche by focusing on cardiovascular interventions, technological innovations, and pharmaceuticals. At its core, Lepu Medical thrives on leveraging its research and development expertise to create products that cater to a broad spectrum of medical needs, particularly in the cardiovascular domain. They manufacture and distribute a wide range of medical devices which include coronary stents, pacemakers, and other related products, enabling them to secure a strong foothold in both domestic and international markets. Revenue generation for Lepu Medical is a multifaceted process that leverages the company's comprehensive vertical integration strategy. The company has strategically developed a robust portfolio not only in medical devices but also in pharmaceuticals and healthcare services. This diversified offering allows them to capture value across the entire patient care continuum—from device manufacturing and pharmaceuticals to post-operative care and services. By continually investing in innovation and expanding their reach through strategic partnerships and acquisitions, Lepu Medical ensures a consistent revenue stream, reinforcing its position within the global healthcare landscape. The company's commitment to quality and technological advancement keeps it competitive, propelling its growth across various health sectors.

Intrinsic Value
19.45 CNY
Undervaluation 39%
Intrinsic Value
Price
L

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
10.9%
=
Net Income
707.3m
/
Revenue
6.5B
What is the Net Margin of Lepu Medical Technology Beijing Co Ltd?

Based on Lepu Medical Technology Beijing Co Ltd's most recent financial statements, the company has Net Margin of 10.9%.